EG vs LYRA · P/E 17, rev $8.03B vs rev $1.5M
Everest Group Ltd (EG) versus Lyra Therapeutics Inc (LYRA) — a side-by-side from cached financials, not a winner call.
Everest Group Ltd (EG) is a insurance - reinsurance company listed on US.
Lyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
Latest reported EG revenue for 2026-06-30 was $8.03B. Net income was $1.21B. Revenue was up 97.4% from 2026-03-31 to 2026-06-30. EG currently screens at market cap $14.52B and trailing P/E 17.2.
Latest reported LYRA revenue for 2024-12-31 was $1.5M. Net income was -$93.4M. Revenue was down 1.5% from 2023-12-31 to 2024-12-31. LYRA currently screens at market cap $14.4M.
EG currently screens at market cap $14.52B and trailing P/E 17.2. LYRA currently screens at market cap $14.4M.
Not investment advice. Open the EG and LYRA stock pages for the full models.
Not investment advice.